Learn More
TARGETMOL CHEMICALS INC SAMOTOLISIB 10MG

Supplier: TARGETMOL CHEMICALS INC T6883

Also available in 1 mg 2 mg 5 mg 25 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Samotolisib (LY3023414) is an oral ATP competitive inhibitor of the class I PI3K isoforms DNA-PK and mTOR. Samotolisib (LY3023414) has been used in trials studying the treatment of Neoplasm Solid Tumor COLON CANCER BREAST CANCER and Advanced Cancer among others. purity: 99%
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.